Advertisement

Related Videos

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Peter Clark, MA, MD, FRCP: A Payer Perspective

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Advertisement

Advertisement




May
19
Today In Oncology
Patients With IBD May Be at Risk for VTE After Colorectal Cancer Surgery
Ficerafusp Alfa Plus Pembrolizumab: 2-Year Outcomes in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Daraxonrasib for Previously Treated RAS-Mutated Pancreatic Cancer
Study Finds Methylphenidate-Type Psychostimulants May Reduce Cancer-Related Fatigue
Neoadjuvant Single-Cycle Pembrolizumab for Stage I to III dMMR Colon Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo